BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 21953463)

  • 1. The E3 ubiquitin ligase SMAD ubiquitination regulatory factor 2 negatively regulates Krüppel-like factor 5 protein.
    Du JX; Hagos EG; Nandan MO; Bialkowska AB; Yu B; Yang VW
    J Biol Chem; 2011 Nov; 286(46):40354-64. PubMed ID: 21953463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A colon cancer-derived mutant of Krüppel-like factor 5 (KLF5) is resistant to degradation by glycogen synthase kinase 3β (GSK3β) and the E3 ubiquitin ligase F-box and WD repeat domain-containing 7α (FBW7α).
    Bialkowska AB; Liu Y; Nandan MO; Yang VW
    J Biol Chem; 2014 Feb; 289(9):5997-6005. PubMed ID: 24398687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteasomal degradation of the KLF5 transcription factor through a ubiquitin-independent pathway.
    Chen C; Zhou Z; Guo P; Dong JT
    FEBS Lett; 2007 Mar; 581(6):1124-30. PubMed ID: 17320083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human Kruppel-like factor 5 is a target of the E3 ubiquitin ligase WWP1 for proteolysis in epithelial cells.
    Chen C; Sun X; Guo P; Dong XY; Sethi P; Cheng X; Zhou J; Ling J; Simons JW; Lingrel JB; Dong JT
    J Biol Chem; 2005 Dec; 280(50):41553-61. PubMed ID: 16223724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Smurf2 regulates the degradation of YY1.
    Jeong HM; Lee SH; Yum J; Yeo CY; Lee KY
    Biochim Biophys Acta; 2014 Sep; 1843(9):2005-11. PubMed ID: 24803334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein inhibitor of activated STAT1 interacts with and up-regulates activities of the pro-proliferative transcription factor Krüppel-like factor 5.
    Du JX; Yun CC; Bialkowska A; Yang VW
    J Biol Chem; 2007 Feb; 282(7):4782-4793. PubMed ID: 17178721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Smurf1 ubiquitin ligase targets Kruppel-like factor KLF2 for ubiquitination and degradation in human lung cancer H1299 cells.
    Xie P; Tang Y; Shen S; Wang Y; Xing G; Yin Y; He F; Zhang L
    Biochem Biophys Res Commun; 2011 Apr; 407(1):254-9. PubMed ID: 21382345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nedd8 targets ubiquitin ligase Smurf2 for neddylation and promote its degradation.
    Shu J; Liu C; Wei R; Xie P; He S; Zhang L
    Biochem Biophys Res Commun; 2016 May; 474(1):51-56. PubMed ID: 27086113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pin1 down-regulates transforming growth factor-beta (TGF-beta) signaling by inducing degradation of Smad proteins.
    Nakano A; Koinuma D; Miyazawa K; Uchida T; Saitoh M; Kawabata M; Hanai J; Akiyama H; Abe M; Miyazono K; Matsumoto T; Imamura T
    J Biol Chem; 2009 Mar; 284(10):6109-15. PubMed ID: 19122240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deubiquitinase FAM/USP9X interacts with the E3 ubiquitin ligase SMURF1 protein and protects it from ligase activity-dependent self-degradation.
    Xie Y; Avello M; Schirle M; McWhinnie E; Feng Y; Bric-Furlong E; Wilson C; Nathans R; Zhang J; Kirschner MW; Huang SM; Cong F
    J Biol Chem; 2013 Feb; 288(5):2976-85. PubMed ID: 23184937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TAZ antagonizes the WWP1-mediated KLF5 degradation and promotes breast cell proliferation and tumorigenesis.
    Zhao D; Zhi X; Zhou Z; Chen C
    Carcinogenesis; 2012 Jan; 33(1):59-67. PubMed ID: 22045023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ubiquitin ligase SMURF2 enhances epidermal growth factor receptor stability and tyrosine-kinase inhibitor resistance.
    Ray P; Raghunathan K; Ahsan A; Allam US; Shukla S; Basrur V; Veatch S; Lawrence TS; Nyati MK; Ray D
    J Biol Chem; 2020 Sep; 295(36):12661-12673. PubMed ID: 32669362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Fbw7 tumor suppressor targets KLF5 for ubiquitin-mediated degradation and suppresses breast cell proliferation.
    Zhao D; Zheng HQ; Zhou Z; Chen C
    Cancer Res; 2010 Jun; 70(11):4728-38. PubMed ID: 20484041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oestrogen causes degradation of KLF5 by inducing the E3 ubiquitin ligase EFP in ER-positive breast cancer cells.
    Zhao KW; Sikriwal D; Dong X; Guo P; Sun X; Dong JT
    Biochem J; 2011 Jul; 437(2):323-33. PubMed ID: 21542805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ubiquitination ligase SMURF2 reduces aerobic glycolysis and colorectal cancer cell proliferation by promoting ChREBP ubiquitination and degradation.
    Li Y; Yang D; Tian N; Zhang P; Zhu Y; Meng J; Feng M; Lu Y; Liu Q; Tong L; Hu L; Zhang L; Yang JY; Wu L; Tong X
    J Biol Chem; 2019 Oct; 294(40):14745-14756. PubMed ID: 31409643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The E3 ubiquitin ligase thyroid hormone receptor-interacting protein 12 targets pancreas transcription factor 1a for proteasomal degradation.
    Hanoun N; Fritsch S; Gayet O; Gigoux V; Cordelier P; Dusetti N; Torrisani J; Dufresne M
    J Biol Chem; 2014 Dec; 289(51):35593-604. PubMed ID: 25355311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smad6 interacts with Runx2 and mediates Smad ubiquitin regulatory factor 1-induced Runx2 degradation.
    Shen R; Chen M; Wang YJ; Kaneki H; Xing L; O'keefe RJ; Chen D
    J Biol Chem; 2006 Feb; 281(6):3569-76. PubMed ID: 16299379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coupling of tandem Smad ubiquitination regulatory factor (Smurf) WW domains modulates target specificity.
    Chong PA; Lin H; Wrana JL; Forman-Kay JD
    Proc Natl Acad Sci U S A; 2010 Oct; 107(43):18404-9. PubMed ID: 20937913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SMURF2 and SMAD7 induce SARA degradation via the proteasome.
    Wojtowicz S; Lee S; Chan E; Ng E; Campbell CI; Di Guglielmo GM
    Cell Signal; 2020 Aug; 72():109627. PubMed ID: 32283253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-19b enhances osteogenic differentiation of mesenchymal stem cells and promotes fracture healing through the WWP1/Smurf2-mediated KLF5/β-catenin signaling pathway.
    Huang Y; Xu Y; Feng S; He P; Sheng B; Ni J
    Exp Mol Med; 2021 May; 53(5):973-985. PubMed ID: 34035464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.